Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
011170.KS Stock Summary
In the News
011170.KS Financial details
Company Rating
Buy
Market Cap
6460.75B
Income
220.33B
Revenue
21938.42B
Book val./share
439397.33
Cash/share
-
Dividend
-
Dividend %
-
Employees
4.5K
Optionable
No
Shortable
Yes
Earnings
09 Feb 2023
P/E
27.22
Forward P/E
-
PEG
6.97
P/S
0.27
P/B
0.4
P/C
-
P/FCF
-2.63
Quick Ratio
-
Current Ratio
1.92
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
6.43K
EPS next Y
-
EPS next Q
-
EPS this Y
749.23%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-9.76%
Revenue last 5Y
2.68%
Revenue Q/Q
3.12%
EPS Q/Q
-66.4%
-
-
-
-
SMA20
1.8%
SMA50
2.27%
SMA100
4.47%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
-0.02%
Gross Margin
3%
Oper. Margin
-2%
Profit Margin
1%
Payout
-
Shs Outstand
35.44M
Shs Float
15.3M
-
-
-
-
Target Price
-
52W Range
141000.0-230000.0
52W High
-23.91%
52W Low
+24.11%
RSI
43.81
Rel Volume
1.04
Avg Volume
165.08K
Volume
172.38K
Perf Week
-4.79%
Perf Month
6.38%
Perf Quarter
-1.96%
Perf Half Y
-1.69%
-
-
-
-
Beta
0.794148
-
-
Volatility
3021.69%, 5472.29%
Prev Close
-2.62%
Price
175000
Change
-2.78%
011170.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 464.27K | 482.71K | 441.23K | 356.61K | 528.67K | |
Net income per share | 65.63K | 46.07K | 20.86K | 4.62K | 39.26K | |
Operating cash flow per share | 91.51K | 40.29K | 37.28K | 38.24K | 43.36K | |
Free cash flow per share | 32.36K | -13.62K | 7.08K | 14.77K | 20.74K | |
Cash per share | 142.69K | 137.31K | 111.05K | 109.16K | 130.91K | |
Book value per share | 336.03K | 371.54K | 385.24K | 374.8K | 420.42K | |
Tangible book value per share | 308.38K | 346.93K | 359.68K | 357.09K | 411.25K | |
Share holders equity per share | 336.03K | 371.54K | 385.24K | 374.8K | 420.42K | |
Interest debt per share | 126.04K | 142.07K | 109.26K | 101.57K | 109.44K | |
Market cap | 14326.58B | 10436.87B | 6683.71B | 8945.88B | 6683.72B | |
Enterprise value | 16843.78B | 13893.29B | 8963.32B | 10797.17B | 8746.6B | |
P/E ratio | 6.38 | 6.61 | 9.35 | 56.45 | 4.97 | |
Price to sales ratio | 0.9 | 0.63 | 0.44 | 0.73 | 0.37 | |
POCF ratio | 4.58 | 7.56 | 5.23 | 6.82 | 4.5 | |
PFCF ratio | 12.95 | -22.35 | 27.56 | 17.67 | 9.4 | |
P/B Ratio | 1.25 | 0.82 | 0.51 | 0.7 | 0.46 | |
PTB ratio | 1.25 | 0.82 | 0.51 | 0.7 | 0.46 | |
EV to sales | 1.06 | 0.84 | 0.59 | 0.88 | 0.48 | |
Enterprise value over EBITDA | 4.38 | 4.7 | 4.6 | 9.24 | 3.19 | |
EV to operating cash flow | 5.38 | 10.06 | 7.01 | 8.24 | 5.89 | |
EV to free cash flow | 15.22 | -29.76 | 36.96 | 21.32 | 12.3 | |
Earnings yield | 0.16 | 0.15 | 0.11 | 0.02 | 0.2 | |
Free cash flow yield | 0.08 | -0.04 | 0.04 | 0.06 | 0.11 | |
Debt to equity | 0.24 | 0.2 | 0.18 | 0.16 | 0.13 | |
Debt to assets | 0.37 | 0.35 | 0.3 | 0.29 | 0.32 | |
Net debt to EBITDA | 0.66 | 1.17 | 1.17 | 1.58 | 0.75 | |
Current ratio | 2.17 | 2.06 | 2.64 | 2.4 | 2.06 | |
Interest coverage | 27.35 | 23.65 | 9.78 | 3.32 | 18.03 | |
Income quality | 1.39 | 0.87 | 1.79 | 8.27 | 1.1 | |
Dividend Yield | 0.01 | 0.04 | 0.06 | 0.03 | 0.02 | |
Payout ratio | 0.06 | 0.26 | 0.55 | 1.52 | 0.12 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.09 | 0.08 | 0.09 | 0.08 | 0.06 | |
Capex to operating cash flow | -0.65 | -1.34 | -0.81 | -0.61 | -0.52 | |
Capex to revenue | -0.13 | -0.11 | -0.07 | -0.07 | -0.04 | |
Capex to depreciation | -2.93 | -2.7 | -1.42 | -0.97 | -0.93 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 704.39K | 620.61K | 425.22K | 197.46K | 609.41K | |
ROIC | 0.19 | 0.12 | 0.06 | 0.02 | 0.08 | |
Return on tangible assets | 0.13 | 0.08 | 0.04 | 0.01 | 0.06 | |
Graham Net | -48.24K | -48.42K | -39.2K | -33.68K | -44.8K | |
Working capital | 4434.58B | 4182.5B | 4480.83B | 4008.77B | 4851.57B | |
Tangible asset value | 10544.19B | 11891.3B | 12328.02B | 12239.41B | 14095.9B | |
Net current asset value | 929.27B | 889.11B | 1230.88B | 1202.27B | 2011.96B | |
Invested capital | 0.37 | 0.38 | 0.28 | 0.26 | 0.25 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1026.02B | 862.03B | 906.87B | 866.04B | 1266.83B | |
Average inventory | 1546.56B | 1667.24B | 1618.42B | 1557.13B | 2175.09B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 35.83 | 22.71 | 26.19 | 28.56 | 38.88 | |
Days of inventory on hand | 46.4 | 47.04 | 46.42 | 51.34 | 65.11 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 10.19 | 16.07 | 13.94 | 12.78 | 9.39 | |
Inventory turnover | 7.87 | 7.76 | 7.86 | 7.11 | 5.61 | |
ROE | 0.2 | 0.12 | 0.05 | 0.01 | 0.09 | |
Capex per share | -59.15K | -53.91K | -30.21K | -23.47K | -22.62K |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 129.6K | 150.5K | 162.99K | 160.79K | 165.81K | |
Net income per share | 8.98K | 1.71K | 3.06K | 1.24K | 418.04 | |
Operating cash flow per share | 5.28K | 12.64K | -3.6K | -2.99K | -11.93K | |
Free cash flow per share | -1.33K | 4.6K | -21.69K | -18.74K | -30.65K | |
Cash per share | 125.01K | 130.91K | 0 | 0 | 0 | |
Book value per share | 419.79K | 420.44K | 416.92K | 425.35K | 439.4K | |
Tangible book value per share | 409.8K | 411.27K | 447.35K | 457.96K | 513.41K | |
Share holders equity per share | 419.79K | 420.44K | 416.92K | 425.35K | 439.4K | |
Interest debt per share | 103.04K | 107.51K | -343.95 | -793.49 | -5.06K | |
Market cap | 8277.21B | 7437.49B | 7180.44B | 6169.35B | 4935.48B | |
Enterprise value | 10476.2B | 9500.38B | 7180.44B | 6169.35B | 4935.48B | |
P/E ratio | 6.72 | 31.79 | 17.12 | 36.17 | 86.12 | |
Price to sales ratio | 1.86 | 1.44 | 1.29 | 1.12 | 0.87 | |
POCF ratio | 45.76 | 17.17 | -58.21 | -60.13 | -12.07 | |
PFCF ratio | -182.12 | 47.18 | -9.66 | -9.6 | -4.7 | |
P/B Ratio | 0.58 | 0.52 | 0.5 | 0.42 | 0.33 | |
PTB ratio | 0.58 | 0.52 | 0.5 | 0.42 | 0.33 | |
EV to sales | 2.36 | 1.84 | 1.29 | 1.12 | 0.87 | |
Enterprise value over EBITDA | 16.35 | 28.34 | 20.39 | 102.54 | -23.09 | |
EV to operating cash flow | 57.91 | 21.93 | -58.21 | -60.13 | -12.07 | |
EV to free cash flow | -230.5 | 60.27 | -9.66 | -9.6 | -4.7 | |
Earnings yield | 0.04 | 0.01 | 0.01 | 0.01 | 0 | |
Free cash flow yield | -0.01 | 0.02 | -0.1 | -0.1 | -0.21 | |
Debt to equity | 0.15 | 0.13 | 0 | 0 | 0 | |
Debt to assets | 0.3 | 0.32 | 0.36 | 0.34 | 0.35 | |
Net debt to EBITDA | 3.43 | 6.15 | 0 | 0 | 0 | |
Current ratio | 2.48 | 2.06 | 1.91 | 1.94 | 1.92 | |
Interest coverage | 13.61 | 1.55 | -7.01 | 0.79 | 2.44 | |
Income quality | 0.59 | 7.41 | -1.18 | -2.41 | -28.53 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0.06 | |
Payout ratio | 0 | 0.55 | 0 | 0 | 19.21 | |
Sales general and administrative to revenue | 0 | 0 | 0.05 | 0.05 | 0.05 | |
Research and developement to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Intangibles to total assets | 0.06 | 0.06 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.25 | -0.64 | 5.03 | 5.26 | 1.57 | |
Capex to revenue | -0.05 | -0.05 | -0.11 | -0.1 | -0.11 | |
Capex to depreciation | -1.08 | -1.29 | -2.97 | -2.6 | -2.63 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 291.22K | 127.06K | 169.42K | 109.12K | 64.29K | |
ROIC | 0.02 | 0 | 0 | 0 | -0.02 | |
Return on tangible assets | 0.01 | 0 | 0 | 0 | 0 | |
Graham Net | -31.8K | -44.8K | -248.61K | -238.54K | -272.15K | |
Working capital | 5248.88B | 4851.57B | 4734.89B | 4375.46B | 5045.31B | |
Tangible asset value | 14045.55B | 14095.9B | 0 | 0 | 0 | |
Net current asset value | 2220.33B | 2011.96B | 1409.49B | 866.29B | 1220.57B | |
Invested capital | 0.24 | 0.25 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 30.95 | 0 | 0 | 0 | |
Days of inventory on hand | 55.15 | 51.84 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 2.91 | 0 | 0 | 0 | |
Inventory turnover | 1.63 | 1.74 | 0 | 0 | 0 | |
ROE | 0.02 | 0 | 0.01 | 0 | 0 | |
Capex per share | -6.6K | -8.04K | -18.09K | -15.75K | -18.72K |
011170.KS Frequently Asked Questions
What is Lotte Chemical Corporation stock symbol ?
Lotte Chemical Corporation is a KR stock and trading under the symbol 011170.KS
What is Lotte Chemical Corporation stock quote today ?
Lotte Chemical Corporation stock price is $175000 today.
Is Lotte Chemical Corporation stock public?
Yes, Lotte Chemical Corporation is a publicly traded company.